Listed

Mira Pharmaceuticals, Inc.

MIRANasdaqCIK 1904286Healthcare

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Net income−$1.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$k1,015Research and development, Q3 FY2023, three months to 2023-09-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure387Research and development, Q4 FY2023, three months to 2023-12-31$387.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-28, accession 0001641172-25-001183. Derived: 12-month figure less the 9-month figure.Report this figure762Research and development, Q1 FY2024, three months to 2024-03-31$762.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure614Research and development, Q2 FY2024, three months to 2024-06-30$614.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figure1,067Research and development, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure861Research and development, Q4 FY2024, three months to 2024-12-31$861.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014001. Derived: 12-month figure less the 9-month figure.Report this figure314Research and development, Q1 FY2025, three months to 2025-03-31$314.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure496Research and development, Q2 FY2025, three months to 2025-06-30$496.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure413Research and development, Q3 FY2025, three months to 2025-09-30$412.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure497Research and development, Q4 FY2025, three months to 2025-12-31$496.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-014001. Derived: 12-month figure less the 9-month figure.Report this figure525Research and development, Q1 FY2026, three months to 2026-03-31$524.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure706Research and development, Q2 FY2026, three months to 2026-06-30$705.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Interest expense$k428Interest expense, Q3 FY2023, three months to 2023-09-30$427.7k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure2,731Interest expense, Q4 FY2023, three months to 2023-12-31$2.7m. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-28, accession 0001641172-25-001183. Derived: 12-month figure less the 9-month figure.Report this figure(50.4)Interest expense, Q1 FY2024, three months to 2024-03-31−$50.4k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure(39.4)Interest expense, Q2 FY2024, three months to 2024-06-30−$39.4k. XBRL concept us-gaap:InterestExpense. 10-Q/A filed 2024-08-16, accession 0001493152-24-032816.Report this figure(37.8)Interest expense, Q3 FY2024, three months to 2024-09-30−$37.8k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure(38.1)Interest expense, Q4 FY2024, three months to 2024-12-31−$38.1k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-28, accession 0001641172-25-001183. Derived: 12-month figure less the 9-month figure.Report this figure(21.4)Interest expense, Q1 FY2025, three months to 2025-03-31−$21.4k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figurenot reportednot reportednot reportednot reportednot reported
Net income$k(3,588)Net income, Q3 FY2023, three months to 2023-09-30−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure(5,787)Net income, Q4 FY2023, three months to 2023-12-31−$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001641172-25-001183. Derived: 12-month figure less the 9-month figure.Report this figure(1,718)Net income, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure(1,691)Net income, Q2 FY2024, three months to 2024-06-30−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure(2,044)Net income, Q3 FY2024, three months to 2024-09-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure(2,400)Net income, Q4 FY2024, three months to 2024-12-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014001. Derived: 12-month figure less the 9-month figure.Report this figure(1,784)Net income, Q1 FY2025, three months to 2025-03-31−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure(1,538)Net income, Q2 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure(1,138)Net income, Q3 FY2025, three months to 2025-09-30−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure(5,983)Net income, Q4 FY2025, three months to 2025-12-31−$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-014001. Derived: 12-month figure less the 9-month figure.Report this figure(1,150)Net income, Q1 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure(1,209)Net income, Q2 FY2026, three months to 2026-06-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Diluted EPS$ per share(0.26)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figurenot reported(0.15)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure(0.11)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figure(0.14)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported(0.11)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure(0.09)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure(1.18)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure(0.03)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Basic EPS$ per share(0.26)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figurenot reported(0.15)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure(0.11)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figure(0.14)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported(0.11)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure(0.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure(1.18)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure(0.03)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure

Balance sheet

Cash and equivalents$3.6m, Q2 FY2026
Shareholders' equity$8.2m, Q2 FY2026
Line itemUnitQ1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30period not labelled2025-07-18Q3 FY20252025-09-30period not labelled2025-12-16FY20252025-12-31Q1 FY20262026-03-29Q2 FY20262026-06-30
Cash and equivalents$m3.5Cash and equivalents, Q1 FY2024, at 2024-03-31$3.5m. XBRL concept us-gaap:Cash. 10-Q filed 2024-05-13, accession 0001493152-24-018908.Report this figure2.8Cash and equivalents, Q2 FY2024, at 2024-06-30$2.8m. XBRL concept us-gaap:Cash. 10-Q/A filed 2024-08-16, accession 0001493152-24-032816.Report this figure4.1Cash and equivalents, Q3 FY2024, at 2024-09-30$4.1m. XBRL concept us-gaap:Cash. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure2.8Cash and equivalents, FY2024, at 2024-12-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001493152-26-014001.Report this figure1.2Cash and equivalents, Q1 FY2025, at 2025-03-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure0.7Cash and equivalents, Q2 FY2025, at 2025-06-30$730.5k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figure0.1Cash and equivalents, period not labelled, at 2025-07-18$50.0k. XBRL concept us-gaap:Cash. 10-K filed 2026-03-31, accession 0001493152-26-014001.Report this figure2.6Cash and equivalents, Q3 FY2025, at 2025-09-30$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure0.1Cash and equivalents, period not labelled, at 2025-12-16$50.0k. XBRL concept us-gaap:Cash. 10-K filed 2026-03-31, accession 0001493152-26-014001.Report this figure6.3Cash and equivalents, FY2025, at 2025-12-31$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure0.1Cash and equivalents, Q1 FY2026, at 2026-03-29$80.8k. XBRL concept us-gaap:Cash. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure3.6Cash and equivalents, Q2 FY2026, at 2026-06-30$3.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Current assets$m3.7Current assets, Q1 FY2024, at 2024-03-31$3.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018908.Report this figure2.9Current assets, Q2 FY2024, at 2024-06-30$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q/A filed 2024-08-16, accession 0001493152-24-032816.Report this figure4.2Current assets, Q3 FY2024, at 2024-09-30$4.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure2.9Current assets, FY2024, at 2024-12-31$2.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014001.Report this figure1.4Current assets, Q1 FY2025, at 2025-03-31$1.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure0.8Current assets, Q2 FY2025, at 2025-06-30$832.9k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figurenot reported7.6Current assets, Q3 FY2025, at 2025-09-30$7.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported11.1Current assets, FY2025, at 2025-12-31$11.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure9.4Current assets, Q1 FY2026, at 2026-03-31$9.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure8.2Current assets, Q2 FY2026, at 2026-06-30$8.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Total assets$m3.8Total assets, Q1 FY2024, at 2024-03-31$3.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001493152-24-018908.Report this figure3.0Total assets, Q2 FY2024, at 2024-06-30$3.0m. XBRL concept us-gaap:Assets. 10-Q/A filed 2024-08-16, accession 0001493152-24-032816.Report this figure4.3Total assets, Q3 FY2024, at 2024-09-30$4.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure2.9Total assets, FY2024, at 2024-12-31$2.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001493152-26-014001.Report this figure1.4Total assets, Q1 FY2025, at 2025-03-31$1.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure0.9Total assets, Q2 FY2025, at 2025-06-30$868.3k. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figurenot reported7.6Total assets, Q3 FY2025, at 2025-09-30$7.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported11.1Total assets, FY2025, at 2025-12-31$11.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure9.5Total assets, Q1 FY2026, at 2026-03-31$9.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure8.2Total assets, Q2 FY2026, at 2026-06-30$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Current liabilities$m0.7Current liabilities, Q1 FY2024, at 2024-03-31$652.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018908.Report this figure0.8Current liabilities, Q2 FY2024, at 2024-06-30$796.6k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q/A filed 2024-08-16, accession 0001493152-24-032816.Report this figure0.7Current liabilities, Q3 FY2024, at 2024-09-30$692.8k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure0.7Current liabilities, FY2024, at 2024-12-31$723.3k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001493152-26-014001.Report this figure0.1Current liabilities, Q1 FY2025, at 2025-03-31$106.2k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure0.3Current liabilities, Q2 FY2025, at 2025-06-30$298.5k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figurenot reported0.1Current liabilities, Q3 FY2025, at 2025-09-30$83.9k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported0.7Current liabilities, FY2025, at 2025-12-31$702.1k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure0.1Current liabilities, Q1 FY2026, at 2026-03-31$114.8k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure0.0Current liabilities, Q2 FY2026, at 2026-06-30$40.8k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Total liabilities$m0.7Total liabilities, Q1 FY2024, at 2024-03-31$652.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001493152-24-018908.Report this figure0.8Total liabilities, Q2 FY2024, at 2024-06-30$796.6k. XBRL concept us-gaap:Liabilities. 10-Q/A filed 2024-08-16, accession 0001493152-24-032816.Report this figure0.7Total liabilities, Q3 FY2024, at 2024-09-30$692.8k. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure0.7Total liabilities, FY2024, at 2024-12-31$723.3k. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001493152-26-014001.Report this figure0.1Total liabilities, Q1 FY2025, at 2025-03-31$106.2k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure0.3Total liabilities, Q2 FY2025, at 2025-06-30$298.5k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figurenot reported0.1Total liabilities, Q3 FY2025, at 2025-09-30$83.9k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported0.7Total liabilities, FY2025, at 2025-12-31$702.1k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure0.1Total liabilities, Q1 FY2026, at 2026-03-31$114.8k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure0.0Total liabilities, Q2 FY2026, at 2026-06-30$40.8k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure
Shareholders' equity$m3.2Shareholders' equity, Q1 FY2024, at 2024-03-31$3.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure2.2Shareholders' equity, Q2 FY2024, at 2024-06-30$2.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure3.6Shareholders' equity, Q3 FY2024, at 2024-09-30$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure2.2Shareholders' equity, FY2024, at 2024-12-31$2.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure1.3Shareholders' equity, Q1 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure0.6Shareholders' equity, Q2 FY2025, at 2025-06-30$569.9k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figurenot reported7.5Shareholders' equity, Q3 FY2025, at 2025-09-30$7.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figurenot reported10.4Shareholders' equity, FY2025, at 2025-12-31$10.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure9.3Shareholders' equity, Q1 FY2026, at 2026-03-31$9.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure8.2Shareholders' equity, Q2 FY2026, at 2026-06-30$8.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure

Cash flow

Operating cash flow−$1.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,761)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001493152-24-044747. Derived: 9-month figure less the 6-month figure.Report this figure(1,035)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001641172-25-001183. Derived: 12-month figure less the 9-month figure.Report this figure(1,050)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure(864)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$863.9k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641172-25-024077. Derived: 6-month figure less the 3-month figure.Report this figure(1,842)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022112. Derived: 9-month figure less the 6-month figure.Report this figure(1,805)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014001. Derived: 12-month figure less the 9-month figure.Report this figure(1,630)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure(800)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$799.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001493152-26-037366. Derived: 6-month figure less the 3-month figure.Report this figure(1,097)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022112. Derived: 9-month figure less the 6-month figure.Report this figure(1,135)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-014001. Derived: 12-month figure less the 9-month figure.Report this figure(1,201)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023005.Report this figure(1,206)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001493152-26-037366. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)19.27m, Q3 FY2025
Line itemUnitperiod not labelled2022-06-30period not labelled2022-09-30period not labelled2023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30
Diluted shares (weighted)m shares13.1Diluted shares (weighted), period not labelled, three months to 2022-06-3013,093,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-09-15, accession 0001493152-23-032778.Report this figure13.2Diluted shares (weighted), period not labelled, three months to 2022-09-3013,168,556 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001493152-23-040517.Report this figure17.8Diluted shares (weighted), period not labelled, three months to 2023-03-3117,750,667 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001493152-24-018908.Report this figure13.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3013,313,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q/A filed 2024-08-16, accession 0001493152-24-032816.Report this figure13.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3013,639,197 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001493152-24-044747.Report this figure14.8Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3114,780,885 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure14.8Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3014,780,885 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figure15.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3015,071,915 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure16.6Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3116,645,119 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001641172-25-010301.Report this figure17.0Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3016,986,488 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641172-25-024077.Report this figure19.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3019,274,947 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022112.Report this figure

Shares outstanding: 42.02mShares outstanding, period not labelled, at 2026-08-1042,022,087 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001493152-26-037366.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.